Frédéric Collet

Frédéric Collet was appointed to the board of Advanced Accelerator Applications (AAA) in January 2018, following the completion of a tender offer for the company by Novartis. He has served as the President of Novartis France since 2017, and as Chief Executive of Novartis Oncology in France since 2015. As of 2017, he also heads the Novartis Group Executive Committee, which brings together Novartis Pharmaceuticals and Oncology, Sandoz and Alcon. Frédéric currently sits on the board of the French Pharmaceutical Industry Trade Association (LEEM), is President of the LEEM Cancer Group, and he leads the European Family. From 2009 to 2015, Frédéric was President of Sandoz France. He also served as Vice President of the French Generics and Bio-similars Professional Association (GEMME). Before this, he was General Manager of the Ciba Vision division from 2005 to 2009. Prior to joining Ciba Vision, Frédéric spent 12 years in various managerial roles within the cosmetics division of the Henkel Group. Frédéric graduated from the Institut d’´Etudes Politiques in Paris and holds a Master’s degree in Economic Science from the University of Paris II.

Susanne Schaffert

Susanne Schaffert, Ph.D., Sidonie Golombowski-Daffner was appointed Chairperson and President of Advanced Accelerator Applications (AAA), a Novartis company in October 2019. Prior to this, Sidonie was General Manager, Novartis Pharma GmbH Nürnberg and Country President Germany since 2017. In this capacity, she was also a member of the Supervisory Boards of Novartis Deutschland GmbH and Novartis Pharma GmbH, Country Executive Committee, Innovative Medicines Committee and Pharma Leadership Team Region Europe. As Country President Germany, Sidonie oversaw 7,500 associates across 12 sites, generating $3.9 billion in sales. During her tenure as General Manager of Novartis Pharma Germany, she led the marketing of products in Rare Diseases, Immunology & Dermatology, Neuroscience, Cardiology, Respiratory and Ophthamology. Under her leadership, the team launched the first Cell and Gene therapy in the Pharma Division, Luxturna, for Ophthamology. From 2014 to 2017, Sidonie served as Novartis Worldwide Franchise Head, Respiratory in Basel. She first joined Novartis in 2011, as Head of Primary Care for Germany. Prior to this, Sidonie spent 10 years at Sanofi and its predecessor companies, Sanofi-Aventis and Sanofi-Synthelabo in a variety of leadership positions with increasing responsibility across the pharmaceutical and generic sectors in Germany, at the corporate headquarters in France, and in the Asia-Pacific region. Sidonie first started her career as a management consultant at Roland Berger, where she spent five years advising pharmaceutical clients in the US, Europe, Russia and Japan. Sidonie holds a Ph.D. in Neuroscience from Ludwig Maximilian University of Munich (Germany) and has additional qualifications in Business Administration.

Jessica Toepfer

Jessica Toepfer was appointed to the board of Advanced Accelerator Applications (AAA) in January 2018, following the completion of a tender offer for the company by Novartis. She is a board member of Novartis Group France, as well as the Country CFO and Pharma CFO for Novartis France, since May 2016. With 20 years of finance and business performance experience in the pharmaceutical industry, Jessica has worked across a range of geographies and therapeutic areas with increasing responsibility. She joined Novartis in 1998, as part of Group BPA’s Finance Development Program and after a rotation in Basel, had assigntments over the next four years in Consumer Health Switzerland & Belgium and Pharma Morocco, before becoming Country CFO Norway, from 2003 to 2006. Jessica then returned to Basel as Finance Head Business Franchise CVM and in 2008 was named Head of Business Planning & Analysis Latin America based in Miami. In 2011, she returned to Europe as Country CFO in Portugal and in December 2013, was named CFO Middle East & North Africa (MENA) Cluster in Dubai managing a portfolio of 18 countries. Jessica holds a Bachelor of Science degree in Foreign Service from Georgetown University in Washington D.C., and a Master’s of Business Administration from HEC School of Management in Paris.